组织处理系统市场规模、份额及成长分析(依技术、最终用户、模式及地区)-2025-2032 年产业预测
市场调查报告书
商品编码
1796474

组织处理系统市场规模、份额及成长分析(依技术、最终用户、模式及地区)-2025-2032 年产业预测

Tissue Processing Systems Market Size, Share, and Growth Analysis, By Technology (Vacuum-Based, Microwave-Based), By End User (Hospitals, Clinical Laboratories), By Modality, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 178 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计全球组织处理系统市场在 2023 年的价值将达到 5.395 亿美元,到 2032 年将从 2024 年的 5.7942 亿美元增长到 10.2572 亿美元,在预测期内(2025-2032 年)的复合年增长率为 7.4%。

全球组织处理系统市场正经历强劲发展势头,这得益于组织病理学实验室对自动化工作流程解决方案日益增长的需求。随着慢性病发病率的上升,样本量也随之增加,实验室正在寻求能够提高固定、脱水、透明和包埋过程效率和一致性的系统。供应商目前正在推出模组化仪器,这些仪器具有灵活的编程功能和试剂盒,旨在优化吞吐量并最大限度地减少人为错误。此外,即时追踪和监控系统的进步使技术人员能够主动解决维护问题并保持业务进度。向数位化病理学和无缝自动化的转变进一步提高了实验室效率,促进了高解析度切片的製作,并改善了病理学家和技术人员之间的沟通,最终提高了诊断品质并减少了错误。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与约束

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究

组织处理系统市场规模(依技术及复合年增长率) (2025-2032)

  • 市场概览
  • 真空底座
  • 基于微波
  • 其他的

组织处理系统市场规模(依最终用户和复合年增长率) (2025-2032)

  • 市场概览
  • 医院
  • 临床实验室
  • 学术研究机构
  • 其他的

组织处理系统市场规模(按模式和复合年增长率) (2025-2032)

  • 市场概览
  • 独立
  • 桌上型

组织处理系统市场规模及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 按部门分類的公司份额分析
    • 收益同比对比(2022-2024 年)

主要企业简介

  • Thermo Fisher Scientific Inc.(USA)
  • Leica Biosystems Nussloch GmbH(Germany)
  • F. Hoffmann La Roche Ltd(Switzerland)
  • Sakura Finetek USA, Inc.(USA)
  • Milestone Medicals(Italy)
  • Medite Medical GmbH(Germany)
  • BioGenex(USA)
  • Bio Optica Milano Spa(Italy)
  • Agar Scientific Ltd.(UK)
  • JOKOH Co., Ltd.(Germany)
  • Danaher Corporation(USA)
  • Agilent Technologies, Inc.(USA)
  • PHC Holdings Corporation(Japan)
  • Siemens AG(Germany)
  • Avantor, Inc.(USA)

结论和建议

简介目录
Product Code: SQMIG35A3104

Global Tissue Processing Systems Market size was valued at USD 539.5 million in 2023 and is poised to grow from USD 579.42 million in 2024 to USD 1025.72 million by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The global tissue processing systems market is witnessing significant momentum, fueled by the increasing demand for automated workflow solutions in histopathology laboratories. As the volume of samples grows alongside the rising incidence of chronic diseases, laboratories seek systems that enhance efficiency and consistency in fixation, dehydration, clearing, and embedding processes. Modern providers are introducing modular instruments equipped with flexible programming and reagent cartridges to optimize throughput while minimizing manual mistakes. Additionally, advancements in real-time tracking and monitoring systems allow technicians to preemptively address maintenance issues, safeguarding operational schedules. The transition towards digital pathology and seamless automation further enhances laboratory efficiency, facilitating high-resolution slide generation and improved communication between pathologists and technicians, ultimately advancing diagnostic quality and reducing errors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Processing Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Processing Systems Market Segments Analysis

Global Tissue Processing Systems Market is segmented by Technology, End User, Modality and region. Based on Technology, the market is segmented into Vacuum-Based, Microwave-Based and Others. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Research & Academic Institutions and Others. Based on Modality, the market is segmented into Stand-Alone and Bench-Top. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Processing Systems Market

The global tissue processing systems market is driven by several key trends, including the escalating workload in histopathology laboratories as a result of an increase in chronic diseases and cancer prevalence. As hospitals and diagnostic centers manage a higher volume of biopsies, there is a heightened demand for quicker and standardized tissue processing solutions. Automated systems are essential in this context, as they enhance workflow efficiency, decrease the likelihood of human error, and shorten turnaround times. Furthermore, these advanced systems can process multiple samples at once while preserving tissue integrity, making them essential for institutions striving to ensure reliable diagnostic results.

Restraints in the Global Tissue Processing Systems Market

A significant obstacle in the global tissue processing systems market is the high initial investment required for automated processing units. These advanced systems often incur substantial capital expenses related to installation, calibration, and the training of personnel. Once the necessary infrastructure is in place, there are still ongoing expenses such as maintenance contracts, software upgrades, and consumables, particularly for systems that incorporate artificial intelligence or digital technologies. This substantial upfront financial burden can deter smaller or resource-constrained laboratories from adopting these advanced systems, ultimately impacting their market penetration and growth potential.

Market Trends of the Global Tissue Processing Systems Market

The Global Tissue Processing Systems market is experiencing a noteworthy trend characterized by the integration of automation and predictive monitoring systems. Advanced tissue processors are increasingly being designed with real-time diagnostics, sensor-based alerts, and remote access features that empower laboratories to anticipate and mitigate potential errors. This convergence enhances operational efficiency, significantly reduces downtime, and fosters consistent output quality, allowing labs to optimize throughput while maintaining the integrity of samples. As laboratories embrace these sophisticated technologies, the demand for innovative tissue processing solutions is likely to grow, reflecting an ongoing evolution towards smarter and more reliable laboratory practices.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies

Global Tissue Processing Systems Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Vacuum-Based
  • Microwave-Based
  • Others

Global Tissue Processing Systems Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinical Laboratories
  • Research & Academic Institutions
  • Others

Global Tissue Processing Systems Market Size by Modality & CAGR (2025-2032)

  • Market Overview
  • Stand-Alone
  • Bench-Top

Global Tissue Processing Systems Market Size & CAGR (2025-2032)

  • North America (Technology, End User, Modality)
    • US
    • Canada
  • Europe (Technology, End User, Modality)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Technology, End User, Modality)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Technology, End User, Modality)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technology, End User, Modality)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Biosystems Nussloch GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sakura Finetek USA, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Milestone Medicals (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medite Medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioGenex (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio Optica Milano Spa (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agar Scientific Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JOKOH Co., Ltd. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PHC Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations